🇺🇸 FDA
Pipeline program

Qishen Granules

2016-ZXFZJJ-003

Phase 2 small_molecule active

Quick answer

Qishen Granules for Heart Failure is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Heart Failure
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials